The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
Researchers in the UK started a clinical trial on mixing vaccines in February - today (14 April) a new study will look into mixing Moderna and Novavax doses.
US authorities paused the use of the Johnson & Johnson single dose vaccine as they look into six cases of blood clots that developed in women aged between 18 and 48.
According to the CDC, one in four HIV patients in the United States experience intimate partner violence - which could be anything between physical assault to stalking.
Christine Hancock, Founder and Director at C3 Collaborating for Health, discusses the ongoing issue of health inequality that COVID-19 has exposed, and how to ensure healthy lives for all.
Open Access Government discuss how the Norwegian Minister for Health and Care Services, Bent Høie has navigated his ministries response to the COVID-19 crisis, and his priorities for 2021.
New CDC guidelines suggest that surfaces are a "low-risk" for COVID transmission - cleaning surfaces with detergent or soap once a day should be enough to reduce possible virus levels.
Chris Norton, Managing Director, UK & Ireland, InterSystems, discusses the NHS’ current challenges, integrated care efforts, and the ways data and technology can be harnessed to inform care today, and in a post-COVID world.
According to a new study, by researchers at Danderyd Hospital and Karolinska Institutet in Sweden, 1 in 10 people still experience symptoms of COVID-19 8 months after infection.
The UK's medical authorities cleared continued use of AstraZeneca, but say that 18-29 year olds should take an alternative vaccine to AstraZeneca if possible.
A new study by Washington University School of Medicine suggests that breastfeeding mothers may pass protective COVID-19 antibodies to their babies through breast milk for at least 80 days following vaccination.
